Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Fu Tseng

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
MMWR. Morbidity and Mortality Weekly Report|October 7, 2021
Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021Deborah E Malden, Katia J Bruxvoort, Hung Fu Tseng, et al.
Vaccine|September 5, 2025
Differences in influenza vaccination coverage by race and ethnicity across age groups in the Vaccine Safety Datalink, 2017-18 through 2022-23 influenza seasonsStephanie A Irving, Holly C Groom, Edward A Belongia, et al.
Vaccine|April 28, 2023
Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomesVictoria Greenberg, Gabriela Vazquez-Benitez, Elyse O Kharbanda, et al.
Human Vaccines & Immunotherapeutics|March 15, 2024
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United StatesAna Florea, Lina Sy, Lei Qian, et al.
Vaccine|June 10, 2023
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort studyJennifer H Ku, Lina S Sy, Lei Qian, et al.
JAMA Network Open|January 20, 2023
Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health SystemSara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
The Journal of Infectious Diseases|June 4, 2015
Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster VaccineHung Fu Tseng, Bruno Lewin, Craig M Hales, et al.
Pediatrics|December 28, 2016
Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-OldsHung-Fu Tseng, Lina S Sy, Bradley K Ackerson, et al.
International Journal of Medical Informatics|May 27, 2019
The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety DatalinkChengyi Zheng, Wei Yu, Fagen Xie, et al.
The Journal of Infectious Diseases|December 28, 2021
Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older AdultsKatia J Bruxvoort, Bradley Ackerson, Lina S Sy, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
MMWR. Morbidity and Mortality Weekly Report|October 7, 2021
Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021Deborah E Malden, Katia J Bruxvoort, Hung Fu Tseng, et al.
Vaccine|September 5, 2025
Differences in influenza vaccination coverage by race and ethnicity across age groups in the Vaccine Safety Datalink, 2017-18 through 2022-23 influenza seasonsStephanie A Irving, Holly C Groom, Edward A Belongia, et al.
Vaccine|April 28, 2023
Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomesVictoria Greenberg, Gabriela Vazquez-Benitez, Elyse O Kharbanda, et al.
Human Vaccines & Immunotherapeutics|March 15, 2024
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United StatesAna Florea, Lina Sy, Lei Qian, et al.
Vaccine|June 10, 2023
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort studyJennifer H Ku, Lina S Sy, Lei Qian, et al.
JAMA Network Open|January 20, 2023
Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health SystemSara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
The Journal of Infectious Diseases|June 4, 2015
Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster VaccineHung Fu Tseng, Bruno Lewin, Craig M Hales, et al.
Pediatrics|December 28, 2016
Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-OldsHung-Fu Tseng, Lina S Sy, Bradley K Ackerson, et al.
International Journal of Medical Informatics|May 27, 2019
The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety DatalinkChengyi Zheng, Wei Yu, Fagen Xie, et al.
The Journal of Infectious Diseases|December 28, 2021
Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older AdultsKatia J Bruxvoort, Bradley Ackerson, Lina S Sy, et al.
Pageof 15